Dennis Wijnker's most recent trade in LifeMD Inc was a trade of 25,000 Common Stock done . Disclosure was reported to the exchange on March 31, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
LifeMD Inc | Dennis Wijnker | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 25,000 | 150,000 | - | 0 | Common Stock | |
LifeMD Inc | Dennis Wijnker | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 25,000 | 125,000 | - | 0 | Common Stock | |
LifeMD Inc | Dennis Wijnker | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 80,000 | 100,000 | - | - | Common Stock | |
LifeMD Inc | Dennis Wijnker | Chief Technology Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2022 | 80,000 | 0 | - | - | Stock Option (Right to Buy) | |
LifeMD Inc | Dennis Wijnker | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 20,000 | 20,000 | - | - | Common Stock | |
LifeMD Inc | Dennis Wijnker | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2021 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) |